glasdegib
FDA Approves New Options for AML
The FDA approved two additional treatment options for older patients with AML and patients who are unable to ...
DECEMBER 14, 2018
FDA Approves Daurismo for Certain AML Patients
Glasdegib is the first Hedgehog pathway inhibitor approved for the treatment of acute myeloid leukemia.
NOVEMBER 28, 2018
Load more